Arnold & Porter Advises Diversis Capital on Its Acquisition of Caligor RX Assets

April 22, 2016

London, April 22, 2016 -- Arnold & Porter LLP’s London office advised Los Angeles-based private equity firm Diversis Capital on its recent acquisition of the majority of assets of Caligor RX, a pharmaceutical sourcing and clinical supply chain company based in New Jersey and in the UK. The firm’s legal team advised on the UK corporate, employment and banking aspects of the transaction, and assisted with U.S. and UK pharmaceutical regulatory due diligence.

Arnold & Porter’s team was led by London-based corporate attorney Jeremy Willcocks, and included employment attorney Henry Clinton-Davis; head of the firm’s EU Life Sciences practice, Ian Dodds-Smith; and co-chair of its firm-wide Life Sciences & Healthcare Regulation practice, Daniel Kracov. The firm’s team also included attorneys Ben Kieft and Ewan Townsend resident in London, and Abraham Gitterman of the firm’s Washington, DC office.

Email Disclaimer